1852 and 5 patients with A/A were reported after COVID-19 vaccination and other vaccinations during the vaccine period, respectively. The reporting rate of A/A after COVID-19 vaccination, was significantly higher compared to A/A after other vaccinations (9.5 vs 0.021 per 1 million p<0.0001), however, the rate was still within the range of incidence of A/A in the general population. Only 20 and 14 cases of A/A were reported during the pre-vaccine and pre-COVID-19 period, respectively. Using self-controlled and case centered analyses, there was a significant difference in the reporting rate of A/A between risk period and control period (89% vs 4-6% p < 0.00001). The reporting rate of A/A was not different between manufacturers. Preliminary data from Machine Learning/Confusion Matrix showed 94.97% accuracy to classify prediction of hospitalization using a binary category.